<DOC>
	<DOCNO>NCT01067573</DOCNO>
	<brief_summary>To determine correlation serum leptin level , nitric oxide precede relapse change leptin nitric oxide level exacerbation relapse remit multiple sclerosis patient .</brief_summary>
	<brief_title>The Role Serum Leptin Levels Multiple Sclerosis Disease Activity While Interferon Beta 1a ( Rebif ) Treatment</brief_title>
	<detailed_description>This observational pilot study patient definitive relapsing-remitting multiple sclerosis determine whether correlation serum leptin level serum nitric oxide level clinically observe increase disease activity . Each subject follow 12 month take interferon beta-1a subcutaneous injection 3 time week .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Confirmed diagnosis multiple sclerosis per update McDonald criterion Initiating treatment interferon beta 1a subcutaneous injection minimal dose 22mcg . 1860 year age . Women pregnant breast feeding , intend become pregnant . Stable dose concomitant medication 30 day prior baseline . Efforts make maintain steady dos concomitant medication duration study . Treatment interferon preparation , glatiramer acetate , last 30 day 6 month Natalizumab , mitoxantrone , cyclosporine immunomodulators determine PI . Treatment investigational treatment within past year treatment investigational treatment multiple sclerosis within last year . Any progressive form MS . Known Hypersensitivity interferon beta 1a . Inability administer subcutaneous injection Inability undergo laboratory evaluation . Seropositivity HIV ( medical history ) Diabetes Mellitus Tyle I II ( medical history ) Hepatitis B C ( medical history ) Uncontrolled psychiatric disorder . Any unstable illness investigator 's opinion precludes participation study . Inability maintain compliance study protocol . Implanted device metal would contraindicate MRI . Clinically significant abnormality CBC CMP MMSE &lt; 25</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>MS</keyword>
	<keyword>Serum Leptin Levels relapse</keyword>
	<keyword>Multiple sclerosis</keyword>
	<keyword>relapse</keyword>
</DOC>